Seeking Alpha
22 Aug 2026, 04:31 UTC · 2h ago
Eikon Therapeutics, Inc. (EIKN) Discusses Advances in PARP1 Biology and Next-Generation PARP Inhibitors in Oncology Transcript
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.






